Cencora, Inc.

COR · Large cap · Calculated market cap · $57.3B · as of 2026-09-30

Company Stats

Market Cap: $57.3B; as of Sep 30, 2026
Shares Outstanding: 190.8M
Free Float: 78.1%

Income Statement

Revenue: $321.3B
Operating Income: $2.6B
Net Income: $1.6B
EBITDA: $3.7B
Non-cash Impairment: $837.4M
Revenue Growth, 3Y: 10.4%
FCF Margin, 3Y Avg: 1.1%
FCF Margin, Worst Year: 1.0%

Cash Flow

Free Cash Flow: $3.2B
FCF Yield: 5.6%
Owner FCF Yield: 5.3%

Balance Sheet

Cash & Equivalents: $4.4B

Returns & Capital

Dividends Paid: $437.1M
Dividend Yield: 0.8%
Dividend Payout, 3Y Avg: 26.2%
Share Repurchases: $435.5M
Buyback Yield, 3Y Avg: 1.8%
SBC, 3Y Avg: $140.2M

Cash Flow by Year

Year	Revenue	FCF	Margin
FY2025	$321.3B	$3.2B	1.0%
FY2024	$294.0B	$3.0B	1.0%
FY2023	$262.2B	$3.5B	1.3%
FY2022	$238.6B	$2.2B	0.9%
FY2021	$214.0B	$2.2B	1.0%

Annual filing data through FY ended September 30, 2025; shares and float as of October 27, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.

Company RSS

Earnings

Nov 4, 2026Cencora Sets Fiscal 2027 Adjusted EPS Outlook Aug 5, 2026Cencora Raises Outlook as OneOncology Expands Margins Jun 15, 2026Cencora lifts profit forecast after oncology deal

Other Coverage

October 28, 2026 Deals

Cencora to Buy American Oncology Network at $2.4 Billion Enterprise Value October 27, 2026 Deals

Cencora to Buy American Oncology Network in $2.4 Billion Deal October 26, 2026 Deals

Cencora to Buy American Oncology Network for $2.4 Billion September 28, 2026 QBook

Stronger demand supports expansion as pricing diverges August 14, 2026 Industry Earnings Roundup

Healthcare Earnings: Demand Surges, Costs Bite Back July 4, 2026 Guidance Season

Chipmakers Lead a Guidance Season Almost Free of Cuts

The Tip Desk